Document Type : Original Research

Authors

1 PhD, Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

2 MD, Department of Vascular and Interventional Radiology, School of Medicine, Namazi Hospital, Shiraz University of Medical Sciences, Shiraz, Iran

3 PhD, Department of Biostatistics, School of Public Health, Iran University of Medical Sciences, Tehran, Iran

Abstract

Background: The ability to monitor kidney function after transplantation is one of the major factors to improve care of patients.
Objective: Authors recommend a computerized texture analysis using run-length matrix features for detection of changes in kidney tissue after allograft in ultrasound imaging.
Material and Methods: A total of 40 kidney allograft recipients (28 male, 12 female) were used in this longitudinal study. Of the 40 patients, 23 and 17 patients showed increased serum creatinine (sCr) (increased group) and decreased sCr (decreased group), respectively. Twenty run-length matrix features were used for texture analysis in three normalizations. Correlations of texture features with serum creatinine (sCr) level and differences between before and after follow-up for each group were analyzed. An area under the receiver operating characteristic curve (Az) was measured to evaluate potential of proposed method.
Results: The features under default and 3sigma normalization schemes via linear discriminant analysis (LDA) showed high performance in classifying decreased group with an Az of 1. In classification of the increased group, the best performance gains were determined in the 3sigma normalization schemes via LDA with an Az of 0.974 corresponding to 95.65% sensitivity, 91.30% specificity, 93.47% accuracy, 91.67% PPV, and 95.45% NPV.
Conclusion: Run-length matrix features not only have high potential for characterization but also can help physicians to diagnose kidney failure after transplantation.

Keywords

Introduction

Kidney transplantation is an elective treatment for patients with chronic kidney disease (CKD) and its progression, end-stage renal disease (ESRD) [ 1 ]. Despite recent improvements in treatment, acute rejection leads to graft failure in 12% of cases [ 2 ]. The serum creatinine (sCr) concentration is commonly used as a marker for evaluating kidney graft functioning. Chronic allograft nephropathy appears with increasing interstitial fibrosis and tubular atrophy increasing creatinine [ 3 - 5 ]. It seems that interstitial fibrosis and tubular atrophy can change properties of medical images.

Ultrasonography is the first chosen technique to evaluate kidney function after allograft transplants owing to being in real time, non-invasive, radiation-free, widely available and convenient [ 6 ]. Different tissues have different textures in an ultrasound image, which is made of diverse gray-level intensities. Texture can be simply conceived by human eyes though there is no accurate mathematical definition for it. Various coarse, fine, and smooth patterns as well as spatial variations in the pixel intensities of objects describe an image texture. Although it is difficult to interpret complex patterns, visual inspection can provide a detection of structural abnormalities within an ultrasound image. Yet, a computerized texture analysis has been proposed to improve decision of physicians and reduce patient pain besides avoiding repeat biopsy and laboratory tests. In conventional ultrasound imaging, computerized texture analysis can mathematically detect pathological changes which are not perceivable by human eyes [ 7 , 8 ].

Differentiation of kidney diseases [ 9 - 12 ] and monitoring the progression of CKD stages [ 13 , 14 ] have been possible through texture analysis (TA) in recent studies. It is shown that TA of ultrasound image can differentiate normal cases from medical renal disease (MRD) and cortical cyst [ 9 , 15 , 16 ] as well as to diagnose bacterial infections [ 10 ]. Additionally, more information on this method was provided in this research. As mentioned before, interstitial fibrosis and tubular atrophy are caused via allograft rejection. Thus, these changes can have an influence on kidney texture features.

This study aims to investigate performance of texture features to monitor kidney function after transplanting among recipients. This is the first study using texture analysis to evaluate kidney allograft recipients after long-term follow-up.

Material and Methods

Study Design and image acquisition

Kidney allograft recipients with 3 years follow-up information were considered for enrollment in this longitudinal study. The inclusion criteria are as following: 1) each of the patients received an allograft from a living donor at the Namazi Hospital. 2) All patients were treated with similar immunosuppressive drugs based on steroids, mycophenolate, mofetil, and tacrolimus. 3) The sCr levels were measured by the Jaffe method. 4) Patients were biopsy proven chronic allograft nephropathy. Furthermore, the exclusion criteria are obtained to avoid potential confusion. The exclusion criteria are significant arrhythmia, large perinephric collections, HIV-positive, chronic inflammatory, diabetes, an inter current infection, re-transplant, hydronephrosis, all causes of increased sCr such as pre- or post-renal azotemia and individuals who were alcoholics and/or smokers.

In this study, longitudinal view of ultrasound images were acquired by Accuvix WS80 sonography device (Medison, Seoul, Korea) equipped with 7-11 MHz linear transducer. Ultrasound images were taken before and at follow-up for each recipient. sCr concentrations were determined a few moments before sonography examination. All ultrasound images were taken in same condition and the mid-pole of kidneys was selected for TA.

Body mass index (BMI) was calculated (kg/m2) during a physical examination. BMI was categorized as underweight, normal weight, overweight, obese class I, obese class II and extremely obese class III [ 17 ]. Ultrasound images, BMI and sCr were acquired prior to the allograft procedure and at 3 years follow-up of it.

ROI Selection and Run-length Matrix Features Extraction

One 2-D region of interest (ROI) was selected for each image of the kidney allograft; hence 80 non-overlap ROIs (total before and at follow-up) were selected for TA. To prevent any bias in ROIs selection, they were defined on images by software and checked by a single experienced radiologist.

This study proposed TA using Run-length Matrix (RLM) to find differences of patients image which were divided into 2 groups: before and after 3 years follow-up. RLM evaluates the image in a specific direction to find pixels with the same intensity. Matrix element (i,j) indicates continuous pixel (j) in the kidney region with the same intensityi (i) in the specific direction. In this study, five RLM parameters were used to describe kidney finction: short-run emphasis (SRE), long-run emphasis (LRE), gray-level nonuniformity (GLNU), run-length nonuniformity (RLNU), and fraction of the image in runs (Fraction). They are defined as:

SRE=i=1Naj=1NrP(i,j)j2/i=1Naj=1NrP(i,j) (1)

LRE=i=1Naj=1Nrj2P(i,j)/i=1Naj=1NrP(i,j) (2)

GLNU=j=1Nr(i=1NaP(i,j))2/i=1Naj=1NrP(i,j) (3)

RLNU=i=1Na(j=1NrP(i,j))2/i=1Naj=1NrP(i,j) (4)

Fraction=i=1Naj=1NrP(i,j)/i=1Naj=1NrjP(i,j) (5)

Where Na and Nr are the number of gray levels in the image and different run lengths occurring, respectively. These five parameters are calculated in four directions, including horizontal, vertical, 45-degree (45 Dgr), and 135-degree (135 Dgr).

Pixel Normalization and Standardization

The 20 RLM features were measured for each region in three normalizations, including default, 3-sigma and 1%-99% normalizations. In the default scheme, the intensity of pixels in the kidney region was not changed. However, in 3-sigma and 1%-99% normalization, the pixels intensity of kidney region were normalized in the range of µ±3σ and between 1% and 99% gray-level of total intensity. Where µ and σ are mean and standard deviation of intensities within the kidney images, respectively.

Before analysis, the RLM features were standardized as follows:

xi=xi-µiσi (6)

where xi and xi' are RLM feature before and after standardization process, respectively, μi is mean and σi is standard deviation of the i-th feature. The standard and nonstandard features were analyzed to find good outcome.

Statistical Analysis and Classification

Data were tested for normality by the Kolmogorov–Smirnov test. Paired samples t-test was obtained to find differences between before and after follow-up for each group. An area under the receiver operating characteristic (ROC) curve (Az) was obtained to evaluate performance of classification for before and after follow-up for each group. The two-tailed Pearson correlation test was implemented to find correlation between sCr level and RLM parameters. A P-value of <0.05 was considered statistically significant.

Texture features that showed a significant difference were utilized for computerized multi parameter texture analysis (MPTA). In this regard, linear discriminant analysis (LDA) and principle component analysis (PCA) were used to analyze the data and map them in to a lower dimension. In the final step, the data were classified by K-NN (K=1) classifier. The ROC analysis was employed to compare the performances of classification in different data analysis strategies. Figure 1 shows the computer-aided diagnosis (CAD) processing steps.

Figure 1. Overview of computer-aided diagnosis (CAD) process in the ultrasound kidney images

SPSS version 19 was used for statistical analyses. 95% confidence intervals for sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were computed by R software, version 3.3.1 (R Project for Statistical Computing).

Results

Demographic Data of Patients

40 kidney allograft recipients (28 male, 12 female) aged 38.9±15.02 years (mean age ± standard deviation) were included in this study. Characteristics of the patients are summarized in Table 1 and Figure 2. Among the 40 patients evaluated in the study, sCr level increased and decreased in 23 patients (increased group) and 17 patients (decreased group), respectively (11 male, 6 female). The means of sCr levels for the decreased group before and after follow-up were 3.84±1.52 and 2.78±1.2, respectively (P=0.007) and for increased group were 2.17± 0.94 and 4.39±2.12, respectively (P=0.001).

Increased Group
BMI (Kg/m2) Obesity Class Gender Before Follow-Up Total Age (Mean±SD) Creatinine (Mean±SD) Gender after 3 years Follow-Up Total Age (Mean±SD) Creatinine (Mean±SD)
Male Female Male Female
Underweight < 18.5 1 - 1 26 1.25 1 - 1 26 3.8
Normal 18.5–24.9 14 4 18 40.84±14.63 2.29±1.01 15 3 18 33.09±11.82 3.88±1.86
Overweight 25.0–29.9 2 1 3 42.67±22.48 1.68±0.11 1 2 3 49.2±11.77 7.32±1.74
Obesity 30.0–34.9 I - 1 1 51 2.38 - 1 1 51 5.5
35.0–39.9 II - - - - - - - - - -
Extreme Obesity 40.0 + III - - - - - - - - - -
Decreased Group
Underweight < 18.5 - - - - - 2 - 2 23±6 2.6±0.5
Normal 18.5–24.9 11 3 14 34.85±14.86 3.85±1.57 8 3 11 34.64±13.67 2.98±1.37
Overweight 25.0–29.9 - 1 1 27 5.2 1 2 3 46.67±14.38 2.5±0.37
Obesity 30.0–34.9 I - 2 2 50.5±1.5 2.38 - 1 1 49 1.63
35.0–39.9 II - - - - - - - - - -
Extreme Obesity 40.0 + III - - - - - - - - - -
BMI = Body mass index
Table 1. Demographic characteristics and laboratory data of patients before and at follow-up.

Figure 2. Diagram to report flow of participants through the study.

Correlation between Kidney Function and Sonographic Texture Features

Among the RLM parameters, most indicated a negative correlation with kidney function in all three normalization schemes for the decreased group. The highest correlation coefficients for default, 3sigma and 1%-99% are 135 Dgr_GLNU (r = -0.889, P = 0.005), 135 Dgr_SRE (r = 0.898, P < 0.001) and Horz LRE (r =-0.879, P= 0.001), respectively (Table 2). For the increased group, most significant texture features have significant correlation with sCr (both positive as well as negative) in all three normalization schemes. The highest correlation coefficients for default, 3sigma and 1%-99% are Vert_RLNU (r = 0.832, P = 0.038), Vert_RLNU (r = -0.711, P=0.004) and 135 Dgr_GLNU (r = 0.765, P=0.016), respectively (Table 3).

Normalization Texture Feature Correlation Coefficient (P-value) Paired-Samples T Test (P-value) *Az value
Default Horz_GLNU -0.881 (<0.001) 0.003 0.657 (0.470, 0.845)
Vert_GLNU -0.894 (<0.001) 0.003 0.671 (0.486, 0.856)
Vert_RLNU -0.843 (<0.001) 0.043 0.616 (0.425, 0.807)
45Dgr_GLNU -0.886 (<0.001) 0.004 0.661 (0.473, 0.848)
135Dgr_GLNU -0.889 (<0.001) 0.005 0.664 (0.478, 0.851)
3Sigma Horz_RLNU 0.693 (<0.001) 0.003 0.882 (0.770, 0.995)
Horz_GLNU -0.823 (<0.001) <0.001 0.834 (0.700, 0.967)
Horz_LRE -0.815 (<0.001) <0.001 0.678 (0.479, 0.877)
Horz_SRE 0.828 (<0.001) <0.001 0.699 (0.508, 0.890)
Horz_Fraction 0.824 (<0.001) <0.001 0.692 (0.498, 0.886)
Vert_RLNU -0.571 (<0.001) 0.037 0.619 (0.398, 0.841)
Vert_GLNU -0.829 (<0.001) <0.001 0.761 (0.595, 0.927)
Vert_LRE -0.762 (<0.001) <0.001 0.730 (0.548, 0.913)
Vert_SRE 0.760 (<0.001) <0.001 0.751 (0.578, 0.923)
Vert_Fraction 0.756 (<0.001) <0.001 0.744 (0.568, 0.920)
45Dgr_GLNU -0.826 (<0.001) <0.001 0.758 (0.590, 0.926)
45Dgr_LRE -0.875 (<0.001) <0.001 0.692 (0.498, 0.886)
45Dgr_SRE 0.875 (<0.001) <0.001 0.723 (0.542, 0.905)
45Dgr_Fraction 0.881 (<0.001) <0.001 0.702 (0.513, 0.892)
135Dgr_GLNU -0.829 (<0.001) <0.001 0.761 (0.595, 0.927)
135Dgr_LRE -0.878 (<0.001) <0.001 0.706 (0.518, 0.894)
135Dgr_SRE 0.898 (<0.001) <0.001 0.706 (0.517, 0.894)
135Dgr_Fraction 0.878 (<0.001) <0.001 0.713 (0.527, 0.898)
1%-99% Horz_GLNU -0.792 (<0.001) <0.001 0.727 (0.553, 0.900)
Horz_LRE -0.879 (<0.001) 0.001 0.626 (0.412, 0.841)
Vert_GLNU -0.796 (<0.001) <0.001 0.709 (0.529, 0.889)
Vert_LRE -0.569 (<0.001) <0.001 0.592 (0.381, 0.803)
Vert_SRE 0.635 (<0.001) <0.001 0.595 (0.389, 0.801)
45Dgr_GLNU -0.749 (<0.001) <0.001 0.713 (0.534, 0.892)
135Dgr_GLNU -0.797 (<0.001) <0.001 0.713 (0.534, 0.892)
*Az value was obtained with 95% confidence intervals.
Table 2. Correlations between serum creatinine (sCr) level and run-length matrix feature in three normalization schemes for decreased group before and at follow-up.
Texture Feature Group Texture Feature Correlation Coefficient (P-value) Paired-Samples T Test (P-value) *Az value
Default Horz_RLNU 0.364 (0.017) 0.001 0.779 (0.643, 0.914)
Horz_GLNU -0.580 (0.027) <0.001 0.853 (0.736, 0.969)
Vert_RLNU 0.832 (0.038) <0.001 0.932 (0.864, 1.000)
Vert_GLNU -0.209 (0.004) <0.001 0.866 (0.754, 0.978)
45Dgr_RLNU 0.500 (0.014) <0.001 0.915 (0.838, 0.992)
45Dgr_GLNU -0.182 (0.022) <0.001 0.851 (0.729, 0.972)
135Dgr_RLNU 0.550 (0.001) <0.001 0.926 (0.854, 0.998)
135Dgr_GLNU -0.372 (0.015) <0.001 0.856 (0.739, 0.973)
3Sigma Horz_RLNU -0.192 (0.002) <0.001 0.875 (0.776, 0.974)
Horz_GLNU 0.316 (0.038) <0.001 0.877 (0.777, 0.977)
Vert_RLNU -0.711 (0.004) <0.001 0.924 (0.852, 0.997)
Vert_GLNU 0.630 (0.003) <0.001 0.879 (0.783, 0.975)
Vert_LRE 0.670 (<0.001) 0.049 0.626 (0.459, 0.792)
Vert_Fraction -0.676 (<0.001) 0.040 0.631 (0.465, 0.798)
45Dgr_RLNU -0.243 (0.018) <0.001 0.909 (0.829, 0.990)
45Dgr_GLNU 0.545 (0.042) <0.001 0.870 (0.769, 0.970)
135Dgr_RLNU -0.579 (0.005) <0.001 0.921 (0.846, 0.995)
135Dgr_GLNU 0.513 (0.009) <0.001 0.871 (0.772, 0.971)
135Dgr_LRE 0.696 (<0.001) 0.028 0.635 (0.469, 0.802)
135Dgr_SRE -0.697 (<0.001) 0.035 0.626 (0.456, 0.795)
135Dgr_Fraction -0.699 (<0.001) 0.027 0.629 (0.461, 0.798)
1%-99% Horz_GLNU -0.693 (0.012) <0.001 0.896 (0.804, 0.988)
Horz_LRE 0.287 (0.035) 0.001 0.709 (0.557, 0.861)
Vert_GLNU 0.744 (0.013) <0.001 0.900 (0.808, 0.992)
Vert_LRE 0.456 (0.001) <0.001 0.531 (0.359, 0.703)
Vert_SRE -0.460 (0.001) <0.001 0.507 (0.337, 0.676)
45Dgr_GLNU 0.388 (0.010) <0.001 0.892 (0.794, 0.990)
135Dgr_GLNU 0.765 (0.016) <0.001 0.900 (0.805, 0.994)
*Az value was obtained with 95% confidence intervals.
Table 3. Correlations between serum creatinine (sCr) level and run-length matrix feature in three normalization schemes for increased group before and at follow-up.

Texture Classification

The significant texture features (driven from paired-samples t-test) were implemented for MPTA. The diagnostic performance of the MPTA method for classifying and making a comparison between before and at follow-up in the decreased group is shown in Table 4. According to the normalization role, in 3sigma, RLM features represented the highest performance in terms of sensitivity, specificity, accuracy, PPV and NPV of 100% by LDA. Moreover, classification tasks performed by S.PCA yielded a high discrimination performance in which sensitivity, specificity, accuracy, PPV, and NPV were 94.12%, 88.23%, 91.18%, 88.89%, and 93.75% respectively.

Normalization Method of feature reduction a SEN (%) a SPC (%) ACC (%) a PPV (%) a NPV (%) a Az value Correct classification
Default NS. PCA 47.06 (32.03, 77.08) 41.18 (34.83, 87.14) 44.12 44.43 (07.66, 81.2) 43.75 (03.61, 83.89) 0.484 (0.282, 0.686) 15/34 [44.18%]
S. PCA 58.82 (41.18, 82.35) 64.70 (62.47, 8154) 61.76 62.50 (39.55, 85.45) 61.10 (41.60, 80.60) 0.657 (0.465, 0.849) 21/34 [61.76%]
NS. LDA 82.35 (64.71, 100) 88.23 (67.50, 100) 85.29 87.50 (74.49, 100) 83.30 (66.73, 99.87) 0.927 (0.840, 1.000) 29/34 [85.29%]
S. LDA 82.35 (64.71, 100) 88.23 (67.50, 1.00) 85.29 87.50 (74.49, 100) 83.30 (66.73, 99.87) 0.927 (0.840, 1.000) 29/34 [85.29%]
3sigma NS. PCA 88.23 (47.06, 100) 88.23 (67.50, 100) 88.23 88.23 (76.16, 100) 88.23 (63.10, 100) 0.938 (0.863, 1.000) 30/34 [88.23%]
S. PCA 94.12 (82.35, 100) 88.23 (76.47, 100) 91.18 88.89 (77.70, 100) 93.75 (42.25, 100) 0.962 (0.906, 1.000) 31/34 [91.18%]
NS. LDA 100 100 100 100 100 1 34/34 [100%]
S. LDA 100 100 100 100 100 1 34/34 [100%]
1-99% NS. PCA 52.94 (17.65, 94.12) 41.18 (29.94, 74.26) 47.06 47.37 (10.56, 84.18) 46.67 (11.09, 82.25) 0.505 (0.306, 0.705) 16/34 [47.06%]
S. PCA 70.59 (40.88, 94.12) 88.23 (64.71, 100) 79.41 85.71 (70.56, 100) 75 (64.82, 85.18) 0.841 (0.706, 0.976) 27/34 [79.41%]
NS. LDA 94.12 (61.62, 100) 82.35 (73.38, 100) 88.23 84.21 (76.53, 91.89) 93.33 (85.81, 100) 0.934 (0.856, 1.000) 30/34 [88.23%]
S. LDA 94.12 (61.62, 100) 82.35 (73.38, 100) 88.23 84.21 (76.53, 91.89) 93.33 (85.81, 100) 0.934 (0.856, 1.000) 30/34 [88.23%]
SEN = sensitivity; SPC = specificity; ACC = accuracy; PPV = positive predictive value; NPV = negative predictive value; Az= area under ROC curve; a: Numbers in parentheses are 95% confidence intervals.
Table 4. Correlations between serum creatinine (sCr) level and run-length matrix feature in three normalization schemes for decreased group before and at follow-up.

The diagnostic performance of the MPTA method is shown in Table 5. The best result was achieved in 3sigma, features analyzed by LDA with a 95.65% sensitivity, 91.30% specificity, 93.47% accuracy, 91.67% PPV and 95.45% NPV. While S.PCA indicated high potential with 78.26% sensitivity, specificity, accuracy, PPV and NPV.

Normalization Method of feature reduction a SEN (%) a SPC (%) ACC (%) a PPV (%) a NPV (%) a Az value Correct classification
Default NS. PCA 65.22 (48.54, 86.36) 73.91 (58.01, 94.75) 69.56 71.43 (51.68, 91.18) 68.00 (57.30, 78.70) 0.750 (0.607, 0.894) 32/46 [69.56%]
S. PCA 69.56 (39.18, 87.26) 78.26 (61.37, 94.89) 73.91 76.19 (60.18, 92.20) 72.00 (61.72, 82.28) 0.798 (0.668, 0.928) 34/46 [73.91%]
NS. LDA 86.96 (79.27, 94.79) 91.30 (87.94, 100) 89.13 90.90 (81.25, 100) 87.50 (75.49, 99.51) 0.949 (0.893, 1.000) 41/46 [89.13%]
S. LDA 86.96 (79.27, 94.79) 91.30 (87.94, 100) 89.13 90.90 (81.25, 100) 87.50 (75.49, 99.51) 0.949 (0.893, 1.000) 41/46 [89.13%]
3sigma NS. PCA 78.26 (58.82, 97.21) 69.56 (35.29, 94.12) 73.91 72 (53.51, 90.49) 76.19 (54.86, 97.52) 0.790 (0.65,0.93) 34/46 [73.91%]
S. PCA 78.26 (63.38, 88.96) 78.26 (54.18, 92.22) 78.26 78.26 (64.33, 92.19) 78.26 (63.73, 92.79) 0.828 (0.701, 0.955) 36/46 [78.26%]
NS. LDA 95.65 (76.35, 100) 91.3 (70.66, 100) 93.47 91.67 (83.22, 100) 95.45 (56.81, 100) 0.974 (0.936, 1.000) 43/46 [93.48%]
NS. LDA 95.65 (76.35, 100) 91.3 (70.66, 100) 93.47 91.67 (83.22, 100) 95.45 (56.81, 100) 0.974 (0.936, 1.000) 43/46 [93.48%]
1-99% NS. PCA 65.22 (35.00, 82.35) 69.56 (26.32, 94.12) 67.39 68.18 (45.52, 90.84) 66.67 (53.99, 79.35) 0.743 (0.596, 0.89) 31/46 [67.39%]
S. PCA 82.61 (67.50, 100) 73.91 (70.59, 100) 78.26 76 (61.38, 90.62) 80.95 (58.43, 100) 0.830 (0.712, 0.948) 36/46 [78.26%]
NS. LDA 91.3 (85.02, 100) 82.61 (81.21, 88.90) 86.96 84 (76.11, 91.89) 90.48 (59.51, 100) 0.934 (0.867, 1.000) 40/46 [86.97%]
S. LDA 91.3 82.61 86.96 84 90.48 0.934 (0.867, 1.000) 40/46 [86.97%]
SEN = sensitivity; SPC = specificity; ACC = accuracy; PPV = positive predictive value; NPV = negative predictive value; Az= area under ROC curve; a: Numbers in parentheses are 95% confidence intervals.
Table 5. Diagnostic performance of proposed method in three normalization schemes for increased creatinine group.

ROC Analysis

Distribution data under LDA shows that LDA was more powerful in distinguishing between before and at follow-up for both the increased and decreased groups (Figure 3). Discriminatory power for the RLM features was examined by constructing ROC curves. Figures 4, 5 and 6 show ROC curves of LDA and PCA for the proposed TA. They were plotted on the same graph for each normalization and patient group (decreased and increased) to make a comparison of discriminating power for classification of patients before and at follow-up. In general, LDA had an advantage over PCA in each normalization and group according to a greater Az value. In classification of the decreased group, the best performance is produced in 3sigma normalization with an Az value of 1. Moreover, it was illustrated, in classification of the increased group, LDA showed the best performance in 3sigma normalization, with an Az of 0.974 which corresponding to 95.65% sensitivity, 91.30% specificity, 93.47% accuracy, 91.67% PPV, and 95.45% NPV

Figure 3. Sample distributions for the best results after texture analysis method, linear discriminant analysis (LDA): 3sigma normalization for decreased group (A) and for increased group (B). Most discriminating features (MDF); “1” and “2” represent patients before and after follow-up, respectively.

Figure 4. The diagrams of the receiver operating characteristic (ROC) curve for each texture analysis method in default: (A) decreased group; (B) increased group.

Figure 5. The diagrams of the receiver operating characteristic (ROC) curve for each texture analysis method in 3sigma normalization: (A) decreased group; (B) increased group.

Figure 6. The diagrams of the receiver operating characteristic (ROC) curve for each texture analysis method in 1-99% normalization: (A) decreased group; (B) increased group.

Discussion

The main aim of this study is to assess the potential of texture features in order to monitor kidney function among following up the transplantation recipients using ultrasound imaging.

In all conditions, feature standardization has just an effect on PCA and it leads to improvement in performance. The highest effect regarding to Az value was in 1%-99% normalization for both increased group (NS. PCA vs. S.PCA: 0.743 vs. 0.830) and decreased one (NS. PCA vs. S.PCA: 0.505 vs. 0.841) (Figure 6). It has not had any impacts on LDA. Tables 4 and 5 indicate that normalization reflected improvement on performance and the best performance was obtained by the 3sigma normalization with LDA for both decreased and increased groups with Az value of 1 and 0.974, respectively. According to the RLM features, as the sCr level increases, the non-uniformity of pixel intensities in the ROI also increases.

Over the past a few decades, initial assessments, routine follow-ups, and monitoring of a kidney transplant have been possible via ultrasonography as the primary imaging technique [ 18 ]. Moreover, kidney evaluation has been plausible through advanced ultrasonography techniques, including color Doppler and elastographic imaging. Any information on tissue stiffness is included in the elastographic features. Additionally, tissue deformation resulted from compression can be detected through ultrasound elastography. kidney allograft loss can induce fibrosis and tubular atrophy in transplant recipients [ 19 ].

Many studies have been carried out to assess correlation between kidney function and sonographic finding. In this regard, it has been shown that there is no agreement on the impact of pathology changes on Doppler and elastography findings. Some studies reported correlation between pathological changes and resistance index (RI) or kidney stiffness (KS) [ 20 - 23 ] and some others showed the opposite [ 24 , 25 ]. Our pervious study showed that sonographic quantitative TA can distinguish reject from non-reject kidney transplant with higher accuracy comparing with RI and KS [ 26 ]. In other way, Wybraniec et al,. [ 27 ] and Komuro et al., [ 28 ] indicated that RI correlated with sCr level but Yazici et al,. [ 29 ] showed opposite. Besides, in the term of ellastography, Peng et al., [ 30 ] showed that elastographic findings were correlated with sCr level while in study carried out by Lee et al., no correlation was observed [ 31 ]. Further researches are needed, in Doppler and elato-sonography field to reach agreement on findings.

Moreover, our study indicated that texture parameters have higher correlation coefficients with sCr level comparing to both Doppler and elastographic indices. The main results of our previous study [ 26 ] reveal that TA can monitor kidney function and correlate with pathological results, while the present study indicates that TA can evaluate sCr level of patient after 3years follow-up since allograft transplantation. Our previous results were obtained in normal conditions, while in the present study, owing to the lack of biopsy results, we have to increase the diagnostic accuracy by using normalization and standardization options on texture parameters. In this regard, the best results were achieved on 3sigma normalization. These texture parameters are quantitatively measured by computer software and it has reproducibility capability. But Doppler and elasto-sonography techniques are operated dependently and also can be affected by factors such as skin-allograft distance, peri or intra renal fluid, gender, age and sonicated direction [ 25 , 32 ].

Kidney function monitoring is one of the most critical factors to improve initial diagnosis accuracy after transplantation. Our results indicated that TA can monitor kidney function after transplantation. Further studies with larger dataset should be performed to confirm this result. Moreover, sCr levels were used to assess kidney function and correlate with texture parameters. Cystatin C has an advantage over sCr and can reflect true glomerular filtration rate [ 33 , 34 ]. Besides sex, muscle mass, age and medication can influence sCr level [ 35 , 36 ]. Further studies require to be performed with respect to cystatin C to assess kidney function.

Kidney images were compared with sCr levels and the reference for further investigations. Since the current study was based on image texture analysis and our reference was sCr, other kidney parameters were not considered.

Conclusion

In this study, we propose a new approach of texture features ability for predicting renal function. This method can be used to help physicians monitor kidney dysfunction and identify candidate patients for biopsy after transplantation. It can be used as an axillary technique with Doppler and elastography sonography to improve understandings of conventional ultrasound imaging.

References

  1. Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet: general information and national estimates on chronic kidney disease in the United States, 2010. Atlanta, Department of Health and Human Services, Centers for Disease Control and Prevention; 2010.
  2. Matas A J, Smith J M, Skeans M A, Lamb K E, Gustafson S K, Samana C J, et al. OPTN/SRTR 2011 Annual Data Report: kidney. Am J Transplant. 2013; 13 Suppl 1:11-46. DOI | PubMed
  3. Forbes J M, Hewitson T D, Becker G J, Jones C L. Ischemic acute renal failure: long-term histology of cell and matrix changes in the rat. Kidney Int. 2000; 57:2375-85. DOI
  4. Simmonds M J. Using genetic variation to predict and extend long-term kidney transplant function. Transplantation. 2015; 99:2038-48. DOI
  5. Merhi B, Bayliss G, Gohh R Y. Role for urinary biomarkers in diagnosis of acute rejection in the transplanted kidney. World J Transplant. 2015; 5:251-60. Publisher Full Text | DOI | PubMed
  6. Wymer D C. Imaging the Chronic Kidney Disease Patient: Clinical Approaches, Utility and Complications. Chronic Renal Disease. 2015;890-6. DOI
  7. Castellano G, Bonilha L, Li L M, Cendes F. Texture analysis of medical images. Clin Radiol. 2004; 59:1061-9. DOI | PubMed
  8. Abbasian Ardakani A, Gharbali A, Saniei Y, Mosarrezaii A, Nazarbaghi S. Application of Texture Analysis in Diagnosis of Multiple Sclerosis by Magnetic Resonance Imaging. Glob J Health Sci. 2015; 7:68-78. Publisher Full Text | DOI | PubMed
  9. Raja K B, Madheswaran M, Thyagarajah K. Texture pattern analysis of kidney tissues for disorder identification and classification using dominant Gabor wavelet. Machine Vision and Applications. 2010; 21:287-300.
  10. Feature extraction of kidney ultrasound images based on intensity histogram and gray level co-occurrence matrix. Sixth Asia Modelling Symposium; Bali, Indonesia: IEEE; 2012.DOI
  11. Attia MW, Abou-Chadi F, Moustafa HE-D, Mekky N. Classification of ultrasound kidney images using PCA and neural networks. International Journal of Advanced Computer Science and Applications. 2015; 6:53-7.
  12. Subramanya M, Kumar V, Mukherjee S, Saini M. SVM-based CAC system for B-mode kidney ultrasound images. J Digit Imaging. 2015; 28:448-58. DOI
  13. Analysis of ultrasound images for identification of Chronic Kidney Disease stages. First International Conference on Networks & Soft Computing (ICNSC2014); Guntur, India: IEEE. 2014. p. 19-20.DOI
  14. Stage diagnosis for Chronic Kidney Disease based on ultrasonography. 11th International Conference on Fuzzy Systems and Knowledge Discovery (FSKD); Xiamen, China: IEEE; 2014.DOI
  15. Raja K B, Madheswaran M, Thyagarajah K. Ultrasound kidney image analysis for computerized disorder identification and classification using content descriptive power spectral features. J Med Syst. 2007; 31:307-17. DOI | PubMed
  16. Raja K B, Madheswaran M, Thyagarajah K. A hybrid fuzzy-neural system for computer-aided diagnosis of ultrasound kidney images using prominent features. J Med Syst. 2008; 32:65-83. DOI
  17. National Heart L, Institute B. Classification of overweight and obesity by BMI, waist circumference, and associated disease risks. Retrieved March. 2015; 12:2015.
  18. Parthipun A, Pilcher J. Renal transplant assessment: sonographic imaging. Ultrasound Clinics. 2010; 5:379-99. DOI
  19. Fletcher J T, Nankivell B J, Alexander S I. Chronic allograft nephropathy. Pediatr Nephrol. 2009; 24:1465-71.
  20. Peters B, Stegmayr B, Mölne J, Haux SB, Hadimeri H. High Resistive Index in Transplant Kidneys Is a Possible Predictor for Biopsy Complications. Transplant Proc. 2016; 48:2714-17. DOI | PubMed
  21. Liu J, Blumfield A, Trivedi M, Mishra N, Mohammed O, Lin J, et al. Does Assessing Preimplantation Kidney Biopsy and Pump Resistive Index Values Predict Kidney Allograft Survival?. Transplantation. 2018; 102:S32. DOI
  22. Yang J, Wang F, Pan W, Ruan L, Ai H. Correlation between ultrasound elastography parameters and renal function after kidney transplantation. Int J Clin Exp Med. 2017; 10:3211-7.
  23. Ghonge N P, Mohan M, Kashyap V, Jasuja S. Renal Allograft Dysfunction: Evaluation with Shear-wave Sonoelastography. Radiology. 2018; 288:146-52. DOI | PubMed
  24. Gao J, Rubin J M, Weitzel W, Lee J, Dadhania D, Kapur S, et al. Comparison of Ultrasound Corticomedullary Strain with Doppler Parameters in Assessment of Renal Allograft Interstitial Fibrosis/Tubular Atrophy. Ultrasound Med Biol. 2015; 41:2631-9. DOI | PubMed
  25. Sommerer C, Scharf M, Seitz C, Millonig G, Seitz H K, Zeier M, et al. Assessment of renal allograft fibrosis by transient elastography. Transpl Int. 2013; 26:545-51. DOI | PubMed
  26. Abbasian Ardakani A, Mohammadi A, Khalili Najafabad B, Abolghasemi J. Assessment of Kidney Function After Allograft Transplantation by Texture Analysis. Iran J Kidney Dis. 2017; 11:157-64. PubMed
  27. Wybraniec M T, Bożentowicz-Wikarek M, Chudek J, Mizia-Stec K. Pre-procedural renal resistive index accurately predicts contrast-induced acute kidney injury in patients with preserved renal function submitted to coronary angiography. The International Journal of Cardiovascular Imaging. 2017; 33:595-604.
  28. Komuro K, Yokoyama N, Shibuya M, Soutome K, Hirose M, Yonezawa K, et al. Associations between increased renal resistive index and cardiovascular events. J Med Ultrasonics. 2016; 43:263-70. DOI | PubMed
  29. Yazici B, Oral A, Gokalp C, Akgün A, Toz H, Ozbek S S, et al. Evaluation of renal transplant scintigraphy and resistance index performed within 2 days after transplantation in predicting long-term graft function. Clin Nucl Med. 2015; 40:548-52. DOI
  30. Peng L, Zhong T, Fan Q, Liu Y, Wang X, Wang L. Correlation analysis of renal ultrasound elastography and clinical and pathological changes in patients with chronic kidney disease. Clin Nephrol. 2017; 87:293-300. DOI | PubMed
  31. Lee J, Oh Y T, Joo D J, Ma B G, Lee A L, Lee J G, et al. Acoustic Radiation Force Impulse Measurement in Renal Transplantation: A Prospective, Longitudinal Study With Protocol Biopsies. Medicine. 2015; 94:e1590. Publisher Full Text | DOI | PubMed
  32. Bota S, Bob F, Sporea I, Sirli R, Popescu A. Factors that influence kidney shear wave speed assessed by acoustic radiation force impulse elastography in patients without kidney pathology. Ultrasound Med Biol. 2015; 41:1-6. DOI | PubMed
  33. Randers E, Erlandsen E J. Serum cystatin C as an endogenous marker of the renal function--a review. Clin Chem Lab Med. 1999; 37:389-95. DOI | PubMed
  34. Gökkuşu C A, Özden T A, Gül H, Yıldız A. Relationship between plasma Cystatin C and creatinine in chronic renal diseases and Tx-transplant patients. Clin Biochem. 2004; 37:94-7. DOI
  35. Van Acker B A, Koomen G C, Koopman M G, De Waart D R, Arisz L. Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet. 1992; 340:1326-9. PubMed
  36. Andreev E, Koopman M, Arisz L. A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible?. J Intern Med. 1999; 246:247-52. PubMed